Apogee Therapeutics (APGE) Institutional Ownership → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free APGE Stock Alerts $47.13 +1.27 (+2.77%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Apogee Therapeutics (NASDAQ:APGE)CurrentInstitutional OwnershipPercentage79.04%Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$322.17MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$14.19M Get APGE Insider Trade Alerts Want to know when executives and insiders are buying or selling Apogee Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APGE Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Apogee Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/5/2024Wellington Management Group LLP1,591,478$44.36M0.0%+0.3%3.141% 2/15/2024Blackstone Inc.351,810$9.83M0.0%+17.6%0.694% 2/14/2024Braidwell LP681,101$19.03M0.7%+38.7%1.344% 2/14/2024Artia Global Partners LP10,381$290K0.1%N/A0.020% 2/13/2024Affinity Asset Advisors LLC537,093$15.01M2.8%-48.6%1.060% 2/12/2024TD Asset Management Inc100,846$2.82M0.0%+217.2%0.199% Get the Latest News and Ratings for APGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/9/2024Franklin Resources Inc.1,089,780$30.45M0.0%+9.3%2.151% 2/7/2024Jump Financial LLC18,344$513K0.0%N/A0.036% 2/6/2024Swiss National Bank33,000$922K0.0%N/A0.065% 2/1/2024New York State Common Retirement Fund8,969$251K0.0%+113.3%0.018% 2/1/2024Jennison Associates LLC103,744$2.90M0.0%N/A0.205% 1/24/2024China Universal Asset Management Co. Ltd.5,555$155K0.0%N/A0.011% 1/12/2024SG Americas Securities LLC6,607$185K0.0%+34.0%0.013% 12/18/2023Vanguard Group Inc.1,121,764$23.89M0.0%N/A2.214% 12/13/2023Teachers Retirement System of The State of Kentucky22,248$474K0.0%N/A0.044% 12/1/2023Wellington Management Group LLP1,586,729$33.04M0.0%N/A3.131% 11/15/2023RA Capital Management L.P.1,977,901$42.13M0.8%N/A3.903% 11/15/2023RTW Investments LP2,142,591$45.64M1.0%N/A4.229% 11/15/2023Adage Capital Partners GP L.L.C.375,000$7.99M0.0%N/A0.740% 11/15/2023Affinity Asset Advisors LLC1,045,110$22.26M6.3%N/A2.063% 11/14/2023Braidwell LP491,113$10.46M0.3%N/A0.969% 11/14/2023Blackstone Inc.299,122$6.37M0.0%N/A0.590% 11/14/2023 Seven Grand Managers LLC48,198$1.03M1.4%N/A0.095% 11/13/2023FMR LLC4,439,798$89.62M0.0%N/A8.762% 11/8/2023 Vivo Capital LLC400,000$8.52M1.1%N/A0.789% 11/8/2023 Amalgamated Bank2,461$52K0.0%N/A0.005% 11/7/2023New York State Common Retirement Fund4,205$90K0.0%N/A0.008% 11/6/2023Victory Capital Management Inc.15,820$337K0.0%N/A0.031% 11/3/2023Platinum Investment Management Ltd.283,683$6.04M0.2%N/A0.560% 10/27/2023TD Asset Management Inc31,794$677K0.0%N/A0.063% 10/26/2023Strs Ohio4,100$87K0.0%N/A0.008% 10/24/2023Bank of New York Mellon Corp59,660$1.27M0.0%N/A0.118% 10/13/2023SG Americas Securities LLC4,931$105K0.0%N/A0.010% (Data available from 1/1/2016 forward) APGE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APGE shares? During the previous two years, 26 institutional investors and hedge funds held shares of Apogee Therapeutics. The most heavily invested institutionals were FMR LLC ($89.62M), RTW Investments LP ($45.64M), Wellington Management Group LLP ($44.36M), RA Capital Management L.P. ($42.13M), Franklin Resources Inc. ($30.45M), Vanguard Group Inc. ($23.89M), and Braidwell LP ($19.03M).Learn more on APGE's institutional investors. What percentage of Apogee Therapeutics stock is owned by institutional investors? 79.04% of Apogee Therapeutics stock is owned by institutional investors. Learn more on APGE's institutional investor holdings. Which institutional investors have been buying Apogee Therapeutics stock? Of the 26 institutional investors that purchased Apogee Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($4.44M), RTW Investments LP ($2.14M), RA Capital Management L.P. ($1.98M), Wellington Management Group LLP ($1.59M), Vanguard Group Inc. ($1.12M), Affinity Asset Advisors LLC ($1.05M), and Braidwell LP ($681.10K). How much institutional buying is happening at Apogee Therapeutics? Institutional investors have bought a total of 14,942,592 shares in the last 24 months. This purchase volume represents approximately $322.17M in transactions. Which Apogee Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Apogee Therapeutics stock in the last 24 months: Affinity Asset Advisors LLC ($508.02K). How much institutional selling is happening at Apogee Therapeutics? Institutional investors have sold a total of 508,017 shares in the last 24 months. This volume of shares sold represents approximately $14.19M in transactions. Related Companies: ACLX Institutional Ownership IMCR Institutional Ownership SWTX Institutional Ownership IOVA Institutional Ownership IBRX Institutional Ownership DNLI Institutional Ownership KYMR Institutional Ownership VCEL Institutional Ownership DNA Institutional Ownership BEAM Institutional Ownership This page (NASDAQ:APGE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.